Douglas Evan Godshall, President & CEO at Shockwave Medical, Inc. (SWAV), sold 9,100 shares at $186.84 ($1.7M) on 2023-12-15, disclosed to the SEC on 2023-12-18.
Scheduled sale ($1.7M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $186.84 | 1,448 | $271K | 15.8% |
| 2 | $186.84 | 1,448 | $271K | 15.8% |
| 3 | $187.56 | 2,293 | $430K | 25.2% |
| 4 | $187.56 | 2,293 | $430K | 25.2% |
| 5 | $188.47 | 700 | $132K | 7.7% |
| 6 | $190.03 | 359 |
| $68K |
| 4.0% |
| 7 | $190.03 | 359 | $68K | 4.0% |
| 8 | $191.03 | 200 | $38K | 2.2% |
| Total | $187.67 avg | 9,100 | $1.7M | 100% |
| Filing → |
| SWAV | SELL | 2024-01-08 | $2.0M | — | Filing → |
| SWAV | SELL | 2023-11-17 | $1.2M | — | Filing → |
| SWAV | SELL | 2023-10-17 | $2.8M | — | Filing → |